San Diego startup AltheaDx, which developed a molecular test designed to guide therapy for depression and anxiety based on a patient’s genetics, is being acquired for $65 million in stock and cash.
Castle Biosciences snaps up San Diego’s AltheaDx to push precision medicine into mental health
San Diego startup AltheaDx, which developed a molecular test designed to guide therapy for depression and anxiety based on a patient's genetics, is being acquired for $65 million in stock and cash.